US expected to increase biodefence spending under Trump, says vaccine maker Bavarian Nordic By Reuters
Bavarian Nordic's Expectations: The CEO of Bavarian Nordic anticipates increased biodefense funding under the incoming Trump administration, despite concerns over vaccine skepticism following the nomination of Robert F. Kennedy Jr. as health secretary.
Market Impact: Shares in Bavarian Nordic and other European vaccine makers fell significantly after Kennedy's nomination, with analysts expressing concern about its potential negative effects on public confidence in vaccines and overall sales.
Trade with 70% Backtested Accuracy
Analyst Views on BAVA

No data
About the author


Event Announcement: The Depositary Receipts Virtual Investor Conference (dbVIC) held on May 15, 2025, has made its company presentations available for online viewing for 90 days.
Company Participation: Notable companies presenting include Bavarian Nordic A/S, Viomi Technology Co., and Infineon Technologies AG, among others, showcasing a range of sectors to investors.

Deutsche Bank Investor Conference: Deutsche Bank is hosting a virtual investor conference on May 15, 2025, featuring presentations from international companies with American Depositary Receipt (ADR) programs, aimed at investors and analysts interested in global markets.
Participation Details: The conference is free to attend, with pre-registration suggested, and will include live Q&A sessions with company representatives from various countries; presentations will also be available for replay afterward.

Deutsche Bank Investor Conference: Deutsche Bank is hosting a virtual Depositary Receipts Investor Conference on May 15, 2025, featuring presentations from international companies with American Depositary Receipt programs, aimed at investors and analysts.
Participation Details: The conference is free to attend, with pre-registration suggested, and will include live Q&A sessions; presentations will be available for replay afterward.

Deutsche Bank Investor Conference Announcement: Deutsche Bank will host its Depositary Receipts Virtual Investor Conference on May 15, 2025, featuring live presentations from international companies with American Depositary Receipt (ADR) programs, aimed at investors and analysts.
Participation Details: The conference is free to attend, with pre-registration suggested, and will include representatives from various countries responding to questions during their presentations.
European Market Recovery: European shares rebounded after a two-month low, with the pan-European STOXX 600 index gaining 0.6%, driven by healthcare stocks and the recovery of heavyweight Novo Nordisk, despite ongoing concerns about U.S. tariffs impacting company earnings.
Economic Indicators and ECB Outlook: Investors are awaiting euro zone inflation data and comments from ECB officials, as recent surveys indicate potential recovery in manufacturing, while Goldman Sachs has lowered its forecast for the European benchmark index due to tariff implications.

Robert F. Kennedy Jr. as Health Secretary: Robert F. Kennedy Jr., a vaccine critic, has been confirmed by the U.S. Senate as Health Secretary, promising to limit his role in vaccine policy despite resistance from the medical community.
Upcoming Vaccine Regulatory Decisions: Several significant regulatory decisions and meetings regarding vaccines are scheduled, including FDA decisions on various vaccines and CDC votes on immunization practices throughout February to June 2024.





